Book a demo
Products & ServicesEvent: August 31, 2026

DTI-Tech developed IFDREAM™, an integrated functional drug response mapping system combining functional drug response profiling, accelerated generation of drug-resistant cancer models, target identification, and investigation of secondary vulnerabilities during resistance.

Published

Signal category

Products & Services

Quote

The next generation of drug discovery: understanding how therapies evolve inside cancer cells

DTI-Tech team

Company

DTI-Tech

We find the protein targets of your drug-like small molecule.

Industry
Research
Location
Bellinzona, CH
Company size
1 employees

DTI-Tech is a privately held company offering services to academia and biotech and pharma companies. Experienced researchers focus exclusively on the drug's target identification, drug screenings and on protein-protein interactions.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.

DTI-Tech developed IFDREAM™, an integrated functional drug response mapping system combining functional drug response profiling, accelerated generation of drug-resistant cancer models, target identification, and investigation of secondary vulnerabilities during resistance. | SeedOps